List of Popular Videos

List of Popular Websites

List of Popular Images and Memes

List of Popular Music

List of New Articles

BlogU

Eli Lilly's obesity pill remains a viable rival to Novo's oral Wegovy despite data that underwhelmed investors

Post date: 2025-08-25 01:00:01

Views: 15

Eli Lilly's orforglipron could have a few advantages over a pill from Novo Nordisk, including a lack of dietary restrictions and easier manufacturing.

Please click Here to read the full story.

Other Top and Latest Questions:

Roth IRA vs. Roth 401(k) contributions: ‘It’s power versus freedom,’ advisor says

The No. 1 thing this Walmart exec looks for in an employee: It’s ‘a total green flag’

8 types of personal loans and how they work

30-year-old makes over $300,000 a year in a hospital—without going to med school: 'I exceeded my expectations'

Goldman says this specialized medical implant stock has more than 50% upside

Kilmar Abrego Garcia taken into ICE custody at appointment

'KPop Demon Hunters' gives Netflix its first box-office win

Kevin O'Leary says he bought Bryant-Jordan card for record-breaking $13 million at auction

Nvidia faces Wall Street's high expectations two years into AI boom

Trump questions whether U.S. can 'do business' in South Korea ahead of president's visit

FAQ

Just copy & paste video embed ...

Share and bookmark ...

All interesting, funny, or ama ...

Home

Post New

Tips

How to Post Video

How to Post Photo

Anti-Invalid Click System

How to make money from this website

There are currently 289 visitor(s) online Now
Advertiser--> | Home | Anti-Invalid Click System |
copyright 2025 Friend Bookmark All rights reserved.